Phase II Study of High Dose Vitamin C Intravenous Infusion in Patients With Resectable or Metastatic Solid Tumor Malignancies (Cohort A)
The purpose of this phase II trial (Cohort A) is to evaluate the safety and efficacy of high dose Vitamin C in patients with resectable select solid tumors, including pancreatic cancer.
Study ID: 1610017688
Trial Phase: Phase II
Trial Sponsor: Weill Medical College of Cornell University
Therapies Used in This Trial: Ascorbic Acid